{"id":"NCT01458106","sponsor":"Bioverativ Therapeutics Inc.","briefTitle":"Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A","officialTitle":"An Open-Label, Multicenter Evaluation of Safety, Pharmacokinetics, and Efficacy of Recombinant Coagulation Factor VIII Fc Fusion Protein, BIIB031, in the Prevention and Treatment of Bleeding Episodes in Pediatric Subjects With Hemophilia A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11","primaryCompletion":"2013-12","completion":"2013-12","firstPosted":"2011-10-24","resultsPosted":"2014-12-12","lastUpdate":"2020-12-19"},"enrollment":71,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hemophilia A"],"interventions":[{"type":"DRUG","name":"BIIB031 (rFVIIIFc)","otherNames":["ELOCTATE","efmoroctocog alfa","antihemophilic factor (recombinant), Fc fusion protein","recombinant coagulation factor VIII Fc fusion protein"]},{"type":"DRUG","name":"FVIII (PK subgroup only)","otherNames":[]}],"arms":[{"label":"All participants","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study is to evaluate the safety of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in previously treated pediatric subjects with hemophilia A. Secondary objectives of this study in this study population are as follows: to evaluate the efficacy of rFVIIIFc for prevention and treatment of bleeding episodes; to evaluate and assess the pharmacokinetics (PK) of rFVIIIFc; and to evaluate rFVIIIFc consumption for prevention and treatment of bleeding episodes.","primaryOutcome":{"measure":"Occurrence of FVIII Inhibitor Development","timeFrame":"Up to Week 26 +/- 7 days, or up to 50 exposure days (EDs) if reached prior to Week 26","effectByArm":[{"arm":"Participants < 6 Years Old","deltaMin":0,"sd":null},{"arm":"Participants 6 to < 12 Years Old","deltaMin":0,"sd":null},{"arm":"All Arms: Total","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"MALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":2},"locations":{"siteCount":23,"countries":["United States","Australia","Hong Kong","Ireland","Netherlands","Poland","South Africa","United Kingdom"]},"refs":{"pmids":["39091324","33719084","25912075"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":35},"commonTop":["Cough","Upper Respiratory Tract Infection","Nasopharyngitis","Abdominal Pain Upper","Vomiting"]}}